05/08/2026

CEO Insights: Perspective of a Company in Transition

September 15, 2024: a date that will remain in THD's history. We celebrated the inauguration of the new facility and 20 years of our history. On that date, THD 2.0 was formally inaugurated, a new era characterized by several key elements.

September 15, 2024: a date that will remain in THD's history. We celebrated the inauguration of the new facility and 20 years of our history. On that date, THD 2.0 was formally inaugurated, a new era characterized by several key elements.

The first is Maturity We had intuited a need: to serve a niche market like proctology, a relatively recent specialization within general surgery. In 20 years, we have succeeded in developing products that have become established worldwide, competing with multinationals and bringing real innovations to market. Today, we can certainly say that this wealth of experience makes us a company fully aware of its know-how and its achieved position of leadership in the Proctology market.

The second is Competence. Developing products for patient health requires constant attention to every aspect of the product design, production, and distribution cycle. We do not accept creating a product unless it provides real benefits to the patient and is developed with the highest standards of rigor and safety. This means mastering the most diverse technologies and optimizing processes, striving to take them to the maximum possible level in order to incorporate unique technical features into our products.

The third is Vision. The challenges we have fought and overcome have given us credibility with the users of our products. Not only that: we have understood new market needs and opened important collaborations with research centers and global key opinion leaders. This understanding allows us today to have a clear vision of what the market will look like tomorrow, anticipating the demands of healthcare professionals.

We can realistically be proud of what we have achieved, with the awareness that we will be able to continue writing our future if we succeed, with perseverance and humility, in pursuing our primary goal of always working for the patient's benefit.

Filippo Bastia CEO

Back
Back